Niche point-of-care endocrine testing–Reviews of intraoperative parathyroid hormone and cortisol monitoring

Li Sheng Chen, Ravinder Jit Singh

Research output: Contribution to journalReview article

Abstract

Point-of-care (POC) testing, which provides quick test results in near-patient settings with easy-to-use devices, has grown continually in recent decades. Among near-patient and on-site tests, rapid intraoperative and intra-procedural assays are used to quickly deliver critical information and thereby improve patient outcomes. Rapid intraoperative parathyroid hormone (ioPTH) monitoring measures postoperative reduction of parathyroid hormone (PTH) to predict surgical outcome in patients with primary hyperparathyroidism, and therefore contributes to the change of parathyroidectomy to a minimally invasive procedure. In this review, recent progress in applying ioPTH monitoring to patients with secondary and tertiary hyperparathyroidism and other testing areas is discussed. In-suite cortisol monitoring facilitates the use of adrenal vein sampling (AVS) for the differential diagnosis of primary aldosteronism and adrenocorticotropic hormone (ACTH)-independent Cushing syndrome. In clinical and psychological research settings, POC testing is also useful for rapidly assessing cortisol in plasma and saliva samples as a biomarker of stress. Careful resource utilization and coordination among stakeholders help to determine the best approach for implementing cost-effective POC testing. Technical advances in integrating appropriate biosensors with microfluidics-based devices hold promise for future real-time POC cortisol monitoring.

Original languageEnglish (US)
Pages (from-to)115-128
Number of pages14
JournalCritical Reviews in Clinical Laboratory Sciences
Volume55
Issue number2
DOIs
StatePublished - Feb 17 2018

Fingerprint

Point-of-Care Systems
Parathyroid Hormone
Hydrocortisone
Monitoring
Testing
Lab-On-A-Chip Devices
Parathyroidectomy
Hyperaldosteronism
Secondary Hyperparathyroidism
Primary Hyperparathyroidism
Cushing Syndrome
Prothrombin Time
Physiologic Monitoring
Biosensing Techniques
Biomarkers
Saliva
Microfluidics
Biosensors
Adrenocorticotropic Hormone
Veins

Keywords

  • adrenal vein sampling
  • cortisol biosensors
  • intra-procedural cortisol monitoring
  • intraoperative PTH
  • parathyroidectomy
  • Point-of-care testing

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Niche point-of-care endocrine testing–Reviews of intraoperative parathyroid hormone and cortisol monitoring. / Chen, Li Sheng; Singh, Ravinder Jit.

In: Critical Reviews in Clinical Laboratory Sciences, Vol. 55, No. 2, 17.02.2018, p. 115-128.

Research output: Contribution to journalReview article

@article{e8aee41589a842c4bf5f8808510336ff,
title = "Niche point-of-care endocrine testing–Reviews of intraoperative parathyroid hormone and cortisol monitoring",
abstract = "Point-of-care (POC) testing, which provides quick test results in near-patient settings with easy-to-use devices, has grown continually in recent decades. Among near-patient and on-site tests, rapid intraoperative and intra-procedural assays are used to quickly deliver critical information and thereby improve patient outcomes. Rapid intraoperative parathyroid hormone (ioPTH) monitoring measures postoperative reduction of parathyroid hormone (PTH) to predict surgical outcome in patients with primary hyperparathyroidism, and therefore contributes to the change of parathyroidectomy to a minimally invasive procedure. In this review, recent progress in applying ioPTH monitoring to patients with secondary and tertiary hyperparathyroidism and other testing areas is discussed. In-suite cortisol monitoring facilitates the use of adrenal vein sampling (AVS) for the differential diagnosis of primary aldosteronism and adrenocorticotropic hormone (ACTH)-independent Cushing syndrome. In clinical and psychological research settings, POC testing is also useful for rapidly assessing cortisol in plasma and saliva samples as a biomarker of stress. Careful resource utilization and coordination among stakeholders help to determine the best approach for implementing cost-effective POC testing. Technical advances in integrating appropriate biosensors with microfluidics-based devices hold promise for future real-time POC cortisol monitoring.",
keywords = "adrenal vein sampling, cortisol biosensors, intra-procedural cortisol monitoring, intraoperative PTH, parathyroidectomy, Point-of-care testing",
author = "Chen, {Li Sheng} and Singh, {Ravinder Jit}",
year = "2018",
month = "2",
day = "17",
doi = "10.1080/10408363.2018.1425975",
language = "English (US)",
volume = "55",
pages = "115--128",
journal = "Critical Reviews in Clinical Laboratory Sciences",
issn = "1040-8363",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - Niche point-of-care endocrine testing–Reviews of intraoperative parathyroid hormone and cortisol monitoring

AU - Chen, Li Sheng

AU - Singh, Ravinder Jit

PY - 2018/2/17

Y1 - 2018/2/17

N2 - Point-of-care (POC) testing, which provides quick test results in near-patient settings with easy-to-use devices, has grown continually in recent decades. Among near-patient and on-site tests, rapid intraoperative and intra-procedural assays are used to quickly deliver critical information and thereby improve patient outcomes. Rapid intraoperative parathyroid hormone (ioPTH) monitoring measures postoperative reduction of parathyroid hormone (PTH) to predict surgical outcome in patients with primary hyperparathyroidism, and therefore contributes to the change of parathyroidectomy to a minimally invasive procedure. In this review, recent progress in applying ioPTH monitoring to patients with secondary and tertiary hyperparathyroidism and other testing areas is discussed. In-suite cortisol monitoring facilitates the use of adrenal vein sampling (AVS) for the differential diagnosis of primary aldosteronism and adrenocorticotropic hormone (ACTH)-independent Cushing syndrome. In clinical and psychological research settings, POC testing is also useful for rapidly assessing cortisol in plasma and saliva samples as a biomarker of stress. Careful resource utilization and coordination among stakeholders help to determine the best approach for implementing cost-effective POC testing. Technical advances in integrating appropriate biosensors with microfluidics-based devices hold promise for future real-time POC cortisol monitoring.

AB - Point-of-care (POC) testing, which provides quick test results in near-patient settings with easy-to-use devices, has grown continually in recent decades. Among near-patient and on-site tests, rapid intraoperative and intra-procedural assays are used to quickly deliver critical information and thereby improve patient outcomes. Rapid intraoperative parathyroid hormone (ioPTH) monitoring measures postoperative reduction of parathyroid hormone (PTH) to predict surgical outcome in patients with primary hyperparathyroidism, and therefore contributes to the change of parathyroidectomy to a minimally invasive procedure. In this review, recent progress in applying ioPTH monitoring to patients with secondary and tertiary hyperparathyroidism and other testing areas is discussed. In-suite cortisol monitoring facilitates the use of adrenal vein sampling (AVS) for the differential diagnosis of primary aldosteronism and adrenocorticotropic hormone (ACTH)-independent Cushing syndrome. In clinical and psychological research settings, POC testing is also useful for rapidly assessing cortisol in plasma and saliva samples as a biomarker of stress. Careful resource utilization and coordination among stakeholders help to determine the best approach for implementing cost-effective POC testing. Technical advances in integrating appropriate biosensors with microfluidics-based devices hold promise for future real-time POC cortisol monitoring.

KW - adrenal vein sampling

KW - cortisol biosensors

KW - intra-procedural cortisol monitoring

KW - intraoperative PTH

KW - parathyroidectomy

KW - Point-of-care testing

UR - http://www.scopus.com/inward/record.url?scp=85041542971&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041542971&partnerID=8YFLogxK

U2 - 10.1080/10408363.2018.1425975

DO - 10.1080/10408363.2018.1425975

M3 - Review article

C2 - 29357735

AN - SCOPUS:85041542971

VL - 55

SP - 115

EP - 128

JO - Critical Reviews in Clinical Laboratory Sciences

JF - Critical Reviews in Clinical Laboratory Sciences

SN - 1040-8363

IS - 2

ER -